Growth Metrics

Nektar Therapeutics (NKTR) Construction in Progress (2016 - 2024)

Historic Construction in Progress for Nektar Therapeutics (NKTR) over the last 15 years, with Q4 2024 value amounting to $245000.0.

  • Nektar Therapeutics' Construction in Progress fell 6684.71% to $245000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $245000.0, marking a year-over-year decrease of 6684.71%. This contributed to the annual value of $245000.0 for FY2024, which is 6684.71% down from last year.
  • Nektar Therapeutics' Construction in Progress amounted to $245000.0 in Q4 2024, which was down 6684.71% from $138000.0 recorded in Q3 2024.
  • In the past 5 years, Nektar Therapeutics' Construction in Progress ranged from a high of $7.2 million in Q4 2021 and a low of $138000.0 during Q3 2024
  • Moreover, its 5-year median value for Construction in Progress was $731500.0 (2023), whereas its average is $1.8 million.
  • Over the last 5 years, Nektar Therapeutics' Construction in Progress had its largest YoY gain of 5704.99% in 2024, and its largest YoY loss of 7172.13% in 2024.
  • Over the past 5 years, Nektar Therapeutics' Construction in Progress (Quarter) stood at $4.7 million in 2020, then surged by 52.4% to $7.2 million in 2021, then crashed by 64.68% to $2.5 million in 2022, then tumbled by 70.79% to $739000.0 in 2023, then crashed by 66.85% to $245000.0 in 2024.
  • Its Construction in Progress was $245000.0 in Q4 2024, compared to $138000.0 in Q3 2024 and $724000.0 in Q2 2024.